Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:negative regulation of planar cell polarity pathway involved in axis elongation
go back to main search page
Accession:GO:2000041 term browser browse the term
Definition:Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in axis elongation.


show annotations for term's descendants       view all columns           Sort by:
 
negative regulation of planar cell polarity pathway involved in axis elongation term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G SFRP1 secreted frizzled related protein 1 JBrowse link 8 41,261,962 41,309,473 RGD:2290271
G SFRP2 secreted frizzled related protein 2 JBrowse link 4 153,780,591 153,789,083 RGD:2290271

Term paths to the root
Path 1
Term Annotations click to browse term
  biological_process 18019
    growth 1010
      negative regulation of growth 250
        negative regulation of developmental growth 109
          negative regulation of planar cell polarity pathway involved in axis elongation 2
Path 2
Term Annotations click to browse term
  biological_process 18019
    biological regulation 12659
      regulation of biological process 11961
        regulation of cellular process 11416
          signal transduction 6313
            cell surface receptor signaling pathway 3214
              cell surface receptor signaling pathway involved in cell-cell signaling 641
                Wnt signaling pathway 534
                  non-canonical Wnt signaling pathway 152
                    Wnt signaling pathway, planar cell polarity pathway 110
                      planar cell polarity pathway involved in axis elongation 6
                        regulation of planar cell polarity pathway involved in axis elongation 2
                          negative regulation of planar cell polarity pathway involved in axis elongation 2
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.